News
Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...
Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...
The European Medicines Agency's (EMA) safety committee has concluded that a potentially dangerous eye condition is a very ...
The European Medicines Agency's safety committee has concluded that the use of Novo Nordisk's popular weight-loss drug Wegovy ...
Wegovy can help people with excess weight and obesity lose weight and improve their health. And you don’t need to drive to a ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in ...
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...
More American teenagers now use the weight-loss drug Wegovy, as doctors and families grow more comfortable with the treatment ...
About 8 million American teens, or 23% of people ages 12 to 19, have obesity, up from 5% in 1980, according to U.S.
Medicare no longer covers Wegovy specifically for weight loss purposes, though coverage may still be available when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results